StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2023 - 12 - 21
1
2023 - 10 - 04
1
2023 - 09 - 14
1
2023 - 08 - 16
1
2023 - 07 - 28
1
2023 - 02 - 23
1
2023 - 02 - 21
1
2022 - 12 - 07
1
2022 - 11 - 28
1
2022 - 11 - 21
1
2022 - 05 - 05
1
2022 - 01 - 04
1
2021 - 05 - 06
1
2021 - 02 - 23
1
2020 - 12 - 18
1
Sector
Health services
15
Health technology
3
Tags
Benefits
1
Breast
2
Cancer
4
Cardiac
1
Collaboration
1
Conference
2
Events
3
Expected
1
Genetic
1
Granted
1
Health
2
Immunotherapy
1
Implant
1
J.p. morgan healthcare conference
1
Lone-star-bio
3
Lung
2
Market
2
Melanoma
1
N/a
3
Patent
1
People
1
Presentation
1
Product-news
1
Publication
1
Report
1
Research
4
Response
1
Risk
1
Sales
1
Study
2
Symposium
1
Technology
1
Test
2
Thc
1
Trial
1
Unique
1
Entities
Agilent technologies, inc.
1
Illumina, inc.
2
Laboratory corporation of america holdings
2
Myriad genetics, inc.
1
Natera, inc.
15
Quest diagnostics incorporated
1
Symbols
AAPL
49
ABB
81
ABBV
50
ABLZF
61
ABT
100
APD
34
ARVL
167
BDX
50
BIO
33
BSX
41
CNXC
32
CSCO
74
DHR
45
DUK
61
ERIC
97
EXTR
51
F
37
FATP
36
FNCTF
349
GE
61
GOOG
50
GOOGL
50
GSK
39
HON
92
INTC
70
JNJ
304
LLY
83
LMT
44
LTUM
50
LYV
36
MDT
82
MMM
73
MOR
36
MS
96
MSFT
86
MT
34
NIPNF
41
NKTR
37
NOC
35
NOK
33
NVO
38
NVS
55
NVSEF
40
OCX
34
ORCL
79
PCRFF
46
PCRFY
46
PFE
34
PHG
46
PPRUF
42
PPRUY
42
SAP
67
SAPGF
53
SNY
205
SNYNF
152
SO
38
T
36
TMO
86
TXMD
33
VZ
74
Exchanges
Nasdaq
15
Nyse
2
Crawled Date
2023 - 12 - 21
1
2023 - 10 - 04
1
2023 - 09 - 14
1
2023 - 08 - 16
1
2023 - 07 - 28
1
2023 - 02 - 23
1
2023 - 02 - 21
1
2022 - 12 - 07
1
2022 - 11 - 28
1
2022 - 11 - 21
1
2022 - 05 - 05
1
2022 - 01 - 04
1
2021 - 05 - 06
1
2021 - 02 - 23
1
2020 - 12 - 18
1
Crawled Time
00:00
7
00:20
4
01:00
4
03:00
1
04:00
1
04:20
1
05:00
5
06:00
1
07:00
1
08:00
4
09:00
3
10:00
3
11:00
1
12:00
18
12:15
1
12:20
3
12:30
4
13:00
17
13:02
1
13:15
7
13:20
3
13:30
4
14:00
24
14:15
1
14:20
3
14:30
5
15:00
15
15:15
1
15:20
5
15:30
4
16:00
10
16:20
3
17:00
8
17:02
1
18:00
4
19:00
4
20:00
7
20:20
1
21:00
6
22:00
6
23:00
3
Source
www.biospace.com
12
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NTRA
crawled time :
15:00
save search
Natera Announces New Study Highlighting the Benefits of Signatera’s Unique Method of Quantifying ctDNA
Published:
2023-12-21
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
57.68%
|
O:
1.62%
H:
5.36%
C:
3.57%
unique
study
benefits
New MRD Publication in Unresectable Stage I-III Lung Cancer Demonstrates Signatera’s Ability to Risk Stratify and Detect Progression Early
Published:
2023-10-04
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
105.51%
|
O:
0.68%
H:
0.24%
C:
-2.46%
lung
cancer
publication
risk
Natera Announces Expanded I-SPY 2 Collaboration to Evaluate Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting
Published:
2023-09-14
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
62.74%
|
O:
0.32%
H:
0.41%
C:
-5.51%
breast
cancer
collaboration
Natera’s Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage
Published:
2023-08-16
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
64.76%
|
O:
0.22%
H:
0.27%
C:
-2.97%
lung
test
granted
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer
Published:
2023-07-28
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
99.29%
|
O:
1.61%
H:
0.92%
C:
-0.37%
cancer
trial
Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
Published:
2023-02-23
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
88.52%
|
O:
0.0%
H:
0.54%
C:
-1.11%
Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call
Published:
2023-02-21
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
80.93%
|
O:
-1.46%
H:
1.46%
C:
-3.72%
conference
Natera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio Breast Cancer Symposium
Published:
2022-12-07
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
132.78%
|
O:
-1.21%
H:
1.93%
C:
0.34%
breast
symposium
cancer
U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with a CAGR of 13.09% and reach $29.28 billion by 2032
Published:
2022-11-28
(Crawled : 15:00)
- prnewswire.com
DGX
|
$127.34
-0.06%
360K
|
Health Services
|
-14.52%
|
O:
-0.13%
H:
0.69%
C:
0.14%
LH
|
$200.16
-0.88%
290K
|
Health Services
|
-16.34%
|
O:
-0.38%
H:
0.3%
C:
-0.87%
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
140.34%
|
O:
-0.82%
H:
1.64%
C:
0.64%
MYGN
F
|
$18.645
-1.45%
240K
|
Health Technology
|
-3.67%
|
O:
-1.63%
H:
2.02%
C:
-2.43%
ILMN
|
$118.86
0.99%
1.2M
|
Health Technology
|
-46.26%
|
O:
-0.76%
H:
1.23%
C:
-0.19%
genetic
expected
market
New Published Study Further Demonstrates the Ability of Natera's mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients
Published:
2022-11-21
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
153.57%
|
O:
-0.79%
H:
2.91%
C:
-0.14%
melanoma
immunotherapy
technology
response
study
Global Cardiac Bio Implant Devices Market Report 2022: Market is Anticipated to Surpass $50 Billion in 2028 from $31.29 Billion in 2021
Published:
2022-05-05
(Crawled : 15:00)
- prnewswire.com
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
160.59%
|
O:
4.53%
H:
0.55%
C:
-5.88%
ILMN
|
$118.86
0.99%
1.2M
|
Health Technology
|
-61.75%
|
O:
-0.68%
H:
0.29%
C:
-4.54%
report
implant
cardiac
market
Natera to Webcast Live Presentation at the 40th Annual J.P. Morgan Healthcare Conference
Published:
2022-01-04
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
-1.11%
|
O:
0.21%
H:
0.6%
C:
-3.8%
health
thc
conference
presentation
j.p. morgan healthcare conference
Increased Maternal Age of Large Populations Worldwide Generates Prodigious Sales Avenues in Non-Invasive Prenatal Testing Market, Says TMR
Published:
2021-05-06
(Crawled : 15:00)
- prnewswire.com
LH
|
$200.16
-0.88%
290K
|
Health Services
|
-26.89%
|
O:
-0.23%
H:
0.91%
C:
0.91%
A
|
$133.98
-2.06%
1.3M
|
Health Technology
|
2.57%
|
O:
-0.79%
H:
0.22%
C:
0.07%
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
-13.92%
|
O:
-1.78%
H:
1.86%
C:
-6.54%
sales
test
Natera to Participate in the Cowen 41st Annual Health Care Conference
Published:
2021-02-23
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
-18.64%
|
O:
-3.78%
H:
4.69%
C:
4.01%
health
U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent
Published:
2020-12-18
(Crawled : 15:00)
- biospace.com/
NTRA
|
$90.25
-0.08%
440K
|
Health Services
|
-10.88%
|
O:
0.49%
H:
1.91%
C:
-0.18%
patent
Gainers vs Losers
63%
37%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
EDBL
|
$7.4
62.64%
12M
|
SINT
|
$0.0366
59.83%
460M
|
Health Technology
RYDE
|
$3.89
42.49%
1.2M
|
n/a
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
LUXH
|
$1.045
26.06%
540K
|
RCAT
|
$1.41
25.89%
3.2M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.